Clinical Trials Browser

Withdrawn × Interventional × Solid Tumor × Clear all

NCT06145802 2026-04-29

Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)

Phase NA Withdrawn

Other solid neoplasm

Solid Tumor

NCT05982522 2026-03-27

IN10018 Combination Therapy in Previously-treated Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03905538 2024-03-01

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Phase EARLY_PHASE1 Withdrawn

Other solid neoplasm

Solid Tumor

NCT05284214 2023-09-15

SALIENT

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03147976 2019-08-28

QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03166176 2019-05-20

TSC1/2_SC

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03166904 2019-05-20

RICTOR_SC

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor

NCT00820768 2018-04-11

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumor

NCT03448211 2018-04-05

A Study of PTS for Patients With Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumor

NCT02656849 2016-07-01

BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumor